We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$183B
AUM Growth
+$2.16B
Cap. Flow
-$8.15B
Cap. Flow %
-4.44%
Top 10 Hldgs %
14.77%
Holding
8,532
New
702
Increased
2,991
Reduced
3,714
Closed
787

Sector Composition

Rank Sector Weight
1 Financials 7.38%
2 Technology 6.63%
3 Healthcare 6.13%
4 Industrials 5.09%
5 Consumer Discretionary 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDGT
7226
Ridgetech Inc
RDGT
$2.74M
0
ITCI
7227
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2K ﹤0.01%
100
SCWX
7228
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$2K ﹤0.01%
206
-905
-81% -$9.7K
IQDE
7229
DELISTED
FlexShares International Quality Dividend Defensive Index Fund
IQDE
$2K ﹤0.01%
73
-2,555
-97% -$58.2K
BPTH
7230
DELISTED
Bio-Path Holdings Inc
BPTH
$2K ﹤0.01%
1
-3
-75% -$10.9K
DMK
7231
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$2K ﹤0.01%
7
-11
-61% -$2.78K
CYTO
7232
DELISTED
Altamira Therapeutics Ltd
CYTO
0
INFI
7233
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$2K ﹤0.01%
500
-15,591
-97% -$38.4K
APTO
7234
DELISTED
Aptose Biosciences, Inc.
APTO
$2K ﹤0.01%
3
IDLB
7235
DELISTED
Invesco FTSE International Low Beta Equal Weight ETF
IDLB
$2K ﹤0.01%
+59
New +$1.5K
ALJJ
7236
DELISTED
ALJ Regional Holdings Inc
ALJJ
$2K ﹤0.01%
657
-2,914
-82% -$11.3K
MENV
7237
DELISTED
AdvisorShares North Square McKee ESG Core Bond ETF
MENV
$2K ﹤0.01%
93
-310
-77% -$7.86K
BDR
7238
DELISTED
Blonder Tongue Laboratories Inc
BDR
$2K ﹤0.01%
2,907
-113,327
-97% -$76.5K
LUB
7239
DELISTED
Luby's Inc.
LUB
$2K ﹤0.01%
619
-7,119
-92% -$25.6K
JRJC
7240
DELISTED
China Finance Online Co., Ltd.
JRJC
$2K ﹤0.01%
55
-212
-79% -$6.79K
CXDC
7241
DELISTED
China XD Plastics Company Limited
CXDC
$2K ﹤0.01%
+441
New +$1.94K
MLPY
7242
DELISTED
Morgan Stanley Cushing MLP High Income Index ETN
MLPY
$2K ﹤0.01%
279
-2,106
-88% -$17.1K
OTEL
7243
DELISTED
Otelco, Inc. Class A
OTEL
$2K ﹤0.01%
249
-1,883
-88% -$12.5K
CEZ
7244
DELISTED
VictoryShares Emerging Market Volatility Wtd ETF
CEZ
$2K ﹤0.01%
60
-5,313
-99% -$139K
QGTA
7245
DELISTED
IQ Leaders GTAA Tracker ETF
QGTA
$2K ﹤0.01%
100
FNJN
7246
DELISTED
Finjan Holdings, Inc.
FNJN
$2K ﹤0.01%
1,413
-607
-30% -$869
TRPX
7247
DELISTED
Therapix Biosciences Ltd.
TRPX
$2K ﹤0.01%
+230
New +$2.02K
SRF
7248
DELISTED
THE CUSHING ROYALTY & INCOME FUND
SRF
$2K ﹤0.01%
194
-4,337
-96% -$41.7K
SLIM
7249
DELISTED
The Obesity ETF
SLIM
$2K ﹤0.01%
95
AGGE
7250
DELISTED
IQ Enhanced Core Bond U.S. ETF
AGGE
$2K ﹤0.01%
+100
New +$1.95K

Similar funds

UBS Group's Q1 2017 Portfolio in Review

As of Q1 2017, UBS Group held 8,532 positions worth $183B, up 1.2% from $181B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $8.15B in Q1 2017, closing 787 positions and reducing 3,714 holdings. Its most notable exit was American Capital Ltd, an estimated $114M position sold in full.

By sector, the portfolio is most concentrated in Financials at 7.4% of assets, up from 7% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS Group opened a new position in Deutsche Bank Aktiengesellschaft worth $33.3M.

  • UBS Group's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 14,119,827 shares worth $33.3M.
  • UBS Group added most to iShares Core MSCI EAFE ETF in Q1 2017, an estimated $527M increase.
  • UBS Group's biggest Q1 2017 reduction was SPDR Gold Trust, cutting an estimated $760M.
  • UBS Group fully exited American Capital Ltd in Q1 2017, selling an estimated $114M.
  • UBS Group's ten largest holdings make up 15% of its $183B portfolio in Q1 2017.
  • UBS Group opened 702 new positions and closed 787 in Q1 2017.
  • UBS Group's portfolio value rose 1.2% quarter-over-quarter to $183B.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.